Virtual Meeting to be held with CEO Valliant on April 21 hosted by Truist.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on FUSN:
- Fusion Pharmaceuticals receives IND clearance for Alpha therapy FPI-2068
- Fusion Pharmaceuticals: First patient dosed in Phase 1 Study of FPI-2059
- Fusion Pharmaceuticals Announces Fourth Quarter 2022 Financial Results and Clinical Program Updates
- Fusion Pharmaceuticals reports Q4 EPS (55c), consensus (56c)
- Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)